Table 21: Dataset - stage complete

Completeness of the dataset (%) - stage complete by cancer site groups summary (persons)
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 75.1% 75.8% 75.5% 66.4% 81.2% 80.0%
Haematology 54.4% 46.5% 58.2% 0.0% 54.4% 73.3%
Head and Neck 84.9% 87.0% 85.3% 75.4% 94.4% 92.7%
Lower GI 84.2% 83.7% 85.1% 68.5% 89.7% 91.4%
Upper GI 74.0% 76.5% 73.5% 72.5% 77.2% 82.7%
HPB 68.4% 70.9% 68.2% 66.4% 76.9% 72.1%
Bronchus & Lung 90.7% 92.3% 90.2% 92.0% 94.4% 92.5%
Melanoma 85.5% 80.5% 88.0% 54.5% 86.4% 93.3%
Breast 86.0% 88.0% 85.9% 84.2% 96.6% 85.2%
Cervix 87.9% 92.3% 86.9% 90.6% 97.3% 94.6%
Other Female Genitals 80.3% 82.8% 80.4% 71.4% 91.2% 88.1%
Prostate 84.2% 85.8% 84.1% 78.4% 89.7% 90.9%
Bladder 76.5% 79.5% 76.6% 66.4% 90.4% 84.6%
Kidney 78.3% 83.9% 77.4% 79.2% 93.6% 85.5%
Thyroid and other endocrine glands 65.8% 70.4% 64.8% 70.4% 74.3% 71.9%
Non Melanoma skin 1.4% 5.0% 1.5% 0.0% 16.8% 1.5%
Brain 0.6% 0.3% 0.7% 0.0% 0.0% 0.7%
CUP 49.5% 39.6% 55.7% 0.0% 50.0% 52.6%
Other invasive cancer 54.1% 45.8% 57.5% 23.0% 46.6% 56.0%